Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

Live Updates

The Bull vs Bear Case for Aehr Test Systems Ahead of Tonight's Q4 Earnings

16 minutes ago

Live

With Aehr Test Systems (NASDAQ:AEHR) reporting Q4 earnings tonight at 4:05 PM ET after the close, here’s the Bull vs Bear case for the stock:

Bull Case

• Q3 bookings hit $37.2 million with a book-to-bill exceeding 3.5x, signaling backlog conversion.
• A lead hyperscaler awarded Aehr the production win for next-generation, higher-power AI accelerators on Sonoma.
• Full-year FY26 revenue guided to the high side of $45 million to $50 million, with a new silicon photonics customer added.
• Full-chain put/call ratio sits at 0.36, reflecting call-heavy positioning.

Bear Case

• Q3 revenue fell 43.67% YoY and missed by 4.91%.
• Gross profit dropped 53.11%, pressuring margins.
• Shares are down 37.29% over the past month, and insider activity skews toward selling.
• The analyst consensus target of $71.33 sits directly on top of the stock’s current price of $71.64.

The Numbers Investors Are Looking for AEHR's Q4 Earnings Tonight to Deliver

1 hour ago

Live

Aehr Test Systems (NASDAQ: AEHR) enters tonight’s fiscal fourth-quarter earnings report with enormous expectations already embedded in its stock price. Shares have soared 425.32% over the past year as investors increasingly view Aehr’s wafer-level burn-in systems as a critical piece of the AI infrastructure buildout.

Aehr jumped 25.69% following fiscal Q3 results, proving the stock can still move sharply higher when execution supports the narrative. However, bears already argue that the company’s fundamentals cannot justify its current valuation, with consensus fair value estimates well below the market price.

The clearest bullish combination would be revenue near the high end of management’s guidance range of $45-$50 million, positive non-GAAP earnings, and a meaningful fiscal 2027 outlook. Investors will be listening closely for hard numbers around AI-related demand, customer expansion, bookings, and the timing of new system orders.

If Aehr delivers those numbers, its AI burn-in story could earn another leg higher. If guidance is vague or near-term results fall short, the gap between the company’s long-term opportunity and its current valuation could quickly become the headline.

Investors are watching Aehr Test Systems (NASDAQ:AEHR) ahead of the company’s fiscal Q4 results due tonight, Tuesday, July 14, at 4:05 PM ET after the market closes. After Aehr’s bookings soared and the stock is up 6.76% on the day, 2 hours ahead of earnings, this report has to prove the business’s AI order book is turning into revenue.

From Bookings Boom to Show-Me Quarter

Last quarter told two stories. Revenue landed at $10.31M, down 43.67% year over year and short of consensus by 4.91%. Yet bookings hit $37.2 million with a book-to-bill exceeding 3.5x, driven by a hyperscaler production win on Sonoma for custom AI accelerator ASICs and a new silicon photonics customer for FOX-XP.

Since then, management’s tone has only escalated. CEO Gayn Erickson told investors the company expects to “return to profitability on a non-GAAP basis in the fourth quarter of fiscal 2026“ and guided full-year revenue to the high side of the $45 million to $50 million range. Shares are up 236.9% year to date, though they have pulled back 32.88% over the past month after a Russell Microcap deletion on June 27.

Consensus Estimates

Backlog Conversion and Margin Are the Whole Game

Tonight, I will be watching four things. First, revenue. Aehr already added $12.2 million in bookings in the first five weeks of Q4 and pushed effective backlog to a record $50.9 million. A number below the roughly $18M consensus would reignite the timing-gap debate that has held the stock back all year.

Second, gross margin. Non-GAAP gross margin was 36.5% in Q3, versus 42.7% a year earlier, pressured by a lighter consumables mix. Erickson expects consumables to eventually run at 30% or more of total revenue. Investors will look at whether the mix normalizes as system shipments scale.

Third, the silicon photonics ramp. Multiple high-power FOX-XP systems for a major photonics customer were scheduled to ship in the fourth quarter of this fiscal year, alongside the initial Sonoma production order from the lead hyperscaler. Management flagged a significant near-term follow-on order tied to fiscal 2027 shipments. Any specific quantification of that FY27 growth would carry real weight given how much of the $2.28B market cap already prices it in.

Fourth, Aehr’s CEO called for a return to profitability starting this quarter. Investors will be looking to see whether the company records profitability this quarter.

Contact [email protected] for any questions or corrections.